Mary Bowden
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Prostate Cancer Treatment and Research
- Cystic Fibrosis Research Advances
- Sarcoma Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 3
- Cystic Fibrosis Research Advances 1
-
- PI3K/AKT/mTOR signaling in cancer 2
- Ubiquitin and proteasome pathways 1
- FOXO transcription factor regulation 1
- Co-authors
- Martin Gleave (8 shared papers)Poul H. Sorensen (2 shared papers)Matthew J. Martin (1 shared paper)Hon S. Leong (1 shared paper)Thomas J. Podor (1 shared paper)Nataliya Melnyk (1 shared paper)Alan So (1 shared paper)Hans Adomat (3 shared papers)
- Journals
- Journal of Biological Chemistry (1 paper)Prostate Cancer and Prostatic Diseases (1 paper)Oncotarget (1 paper)British Journal of Urology (1 paper)Urologic Oncology Seminars and Original Investigations (1 paper)
- Partner nations
- CanadaUnited KingdomUnited States
In The Last Decade
Mary Bowden
10 papers receiving 155 citations
Peers
Comparison fields: 5 of 47
- Cancer Research 26
- Pulmonary and Respiratory Medicine 48
- Endocrinology, Diabetes and Metabolism 19
- Oncology 26
- Molecular Biology 67
Countries citing papers authored by Mary Bowden
This map shows the geographic impact of Mary Bowden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Bowden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Bowden more than expected).
Fields of papers citing papers by Mary Bowden
This network shows the impact of papers produced by Mary Bowden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Bowden. The network helps show where Mary Bowden may publish in the future.
Co-authors
The 25 scholars most cited alongside Mary Bowden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 57 | |
| 2 | 2017 | 19 | |
| 3 | 1992 | 18 | |
| 4 | 2004 | 17 | |
| 5 | 2013 | 11 | |
| 6 | 2020 | 11 | |
| 7 | 2004 | 8 | |
| 8 | 2009 | 6 | |
| 9 | 2020 | 5 | |
| 10 | 2019 | 4 |
About Mary Bowden
Mary Bowden is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Surgery, Oncology and Immunology, having authored 10 papers that have together received 156 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (3 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Bladder and Urothelial Cancer Treatments (1 paper), Ubiquitin and proteasome pathways (1 paper), Immunotherapy and Immune Responses (1 paper), FOXO transcription factor regulation (1 paper), T-cell and B-cell Immunology (1 paper) and Cystic Fibrosis Research Advances (1 paper). The work is most often cited by research in Cancer Research (26 citations), Pulmonary and Respiratory Medicine (48 citations), Endocrinology, Diabetes and Metabolism (19 citations), Oncology (26 citations) and Molecular Biology (67 citations). Mary Bowden has collaborated with scholars based in Canada, United Kingdom and United States. Frequent co-authors include Martin Gleave, Poul H. Sorensen, Matthew J. Martin, Hon S. Leong, Thomas J. Podor, Nataliya Melnyk, Alan So, Hans Adomat, Eliana Beraldi and Janet Woo. Their work appears in journals such as Journal of Biological Chemistry, Prostate Cancer and Prostatic Diseases, Oncotarget, British Journal of Urology and Urologic Oncology Seminars and Original Investigations.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.